Author

L. Fagereng

Institution: Oslo University Hospital

Observed institution: Oslo University Hospital

OpenAlex ID: A5081548989

197P PRIME-ROSE: Merging clinical outcome data from DRUP-like clinical trials

2024 · T.M. Kringelbach, L. Fagereng, et al. · Annals of Oncology · 3

503P The IMPRESS-Norway trial: Improving public cancer care by implementing precision cancer medicine in Norway

2022 · A. Helland, K. Tasken, et al. · Annals of Oncology · 2

114MO Clinical benefit of genomic-guided targeted therapies in patients with rare cancers: First results from the IMPRESS-Norway trial

2025 · K. Puco, E.S. Samdal Steinskog, et al. · Annals of Oncology · 1

1550P Addressing uncertainties of clinical value and improving access for newly authorised indications through DRUG-Access Protocol (DAP)-like platforms: Joint collection and evaluation of real-world evidence

2024 · S.B. van Waalwijk van Doorn-Khosrovani, A.H. Huisman, et al. · Annals of Oncology · 1

1542MO Mapping the scale of off-label use in oncology: An important step in harmonising access

2024 · H.J.L. Timmer, A.H. Huisman, et al. · Annals of Oncology · 1

1235P Enrichment of rare cancers in pragmatic precision cancer medicine trial: Experience from IMPRESS-Norway

2023 · A. Helland, G.O. Hjortland, et al. · Annals of Oncology · 1

285eP Treating BRAF non-V600 alterations (nonV600s) with MEK inhibitors and/or BRAF inhibitors (BRAF/MEKi): Pooled results from DRUP-like clinical trials across Europe

2025 · F.A.J. Verbeek, K. Puco, et al. · Annals of Oncology

3137O IMPRESS-Norway: A nationwide precision-oncology study for off-label targeted therapies - Results from the first 1,740 patients

2025 · S. Brabrand, E.S. Samdal Steinskog, et al. · Annals of Oncology

2291P The evolving landscape of precision diagnostics in Europe requires collaboration

2025 · L. Fagereng, M. Kamal, et al. · Annals of Oncology

47eP Procedures of data merging in precision cancer medicine: The PRIME-ROSE project

2025 · H.V.D. van der Pol, T.M. Kringelbach, et al. · Annals of Oncology

89P Comprehensive genomic profiling of circulating tumor DNA for treatment recommendation: A sub-project of the IMPRESS-Norway trial

2024 · I. Dyvik, L. Fagereng, et al. · Annals of Oncology

706P The IMPRESS-Norway trial: Improving public cancer care by implementing precision cancer medicine in Norway - Safety analysis of the first 126 patients included in the trial

2023 · K. Puco, E.S. Samdal Steinskog, et al. · Annals of Oncology

1315O Key learnings from building: A precision cancer medicine implementation initiative for Norway

2022 · K. Tasken, H.G. Russnes, et al. · Annals of Oncology

Works count: 13

Citation count: 9

H-index: 2

I10-index: